Records containing: Unspecified Adult Solid Tumor, Protocol Specific
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-01-17A Phase I Study of Epothilone B Analog BMS 247550 in Combination With Carboplatin in Recurrent and/or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-01-17A Phase I Dose Escalation of ZD1839 (Iressa®) (Days 1 and 2) and Docetaxel (Day 3) Every 3 Weeks in Patients With an Advanced Solid Tumor
-
CLINICAL_TRIALS study record update · 2013-01-16Phase I Study of OSI-774 (NSC 718781) for Solid Tumors in Patients With Hepatic or Renal Dysfunction
-
CLINICAL_TRIALS study record update · 2013-01-16A Phase I and Pharmacologic Study of 2-Methoxyestradiol in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-01-16Phase I Trial of EF5, an Agent for the Detection of Hypoxia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-01-16A Phase I and Pharmacologic Study of the Proteasome Inhibitor PS-341 in Combination With Paclitaxel and Carboplatin in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2013-01-14A Phase I, Open-Label, Dose-Escalation Study of SB-715992 Administered Days 1-3 of a 21-Day Cycle in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-01-11A Phase I Trial of KRN5500 (NSC 650426) Given as a 72 Hour Continuous IV Infusion Every 21 Days in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-01-10A Phase I Pharmacokinetic Study of STI571 in Patients With Advanced Malignancies and Varying Degrees of Renal Dysfunction for the CTEP-Sponsored Organ Dysfunction Working Group
-
CLINICAL_TRIALS study record update · 2013-01-10A Phase I Study of XL119 (Rebeccamycin Analogue) in Combination With Oxaliplatin in Patients With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-01-10A Phase 1 Study of R-(-)-Gossypol (Ascenta's AT-101) in Combination With Paclitaxel and Carboplatin in Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-01-07Pharmacokinetic and Phase I Study of Sorafenib (BAY 43-9006, NSC 724772, IND 69896) for Solid Tumors and Hematologic Malignancies in Patients With Hepatic or Renal Dysfunction
-
CLINICAL_TRIALS study record update · 2013-01-07Phase I Trial of Arsenic Trioxide in Combination With Pamidronate Disodium
-
CLINICAL_TRIALS study record update · 2013-01-07Phase I Trial of E7389 (Halichondrin B Analog) (NSC# 707389) in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-01-07Phase I Study of Prolonged Low Dose Decitabine (5-Aza-Deoxycytidine, NSC #127716) in Patients With Biopsiable Advanced Cancers Refractory to Standard Therapy
-
CLINICAL_TRIALS study record update · 2012-12-24A Phase I Study of Capecitabine, Oxaliplatin, Bevacizumab, and RAD001 (XELOX-A-Ev) for Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-12-17Phase I Single-Dose Safety and Phamacokinetics Clinical Study of Resveratrol AKA IRB 2003-424
-
CLINICAL_TRIALS study record update · 2012-12-06A Randomized Comparison of Oral Methadone as a "First-Switch" Opioid Versus Opioid Switching Between Sustained-Release Morphine and Oxycodone for Oncology-Hematology Outpatients With Pain Management Problems: The "Simply Rotate" Study
-
CLINICAL_TRIALS study record update · 2012-11-30A Phase I, Multi-Center, Open Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR-104 Given Every 3 Weeks in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-11-22Phase I Trial of Oral Etoposide in Combination With Celecoxib in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2012-11-12Phase I Trial of Oral Cyclophosphamide in Combination With Celecoxib in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2012-11-12A Phase I Study of Regulatory T Cell Depletion With Denileukin Diftitox Followed by Active Immunotherapy With Autologous Dendritic Cells Infected With CEA-6D Expressing Fowlpox-Tricom in Patients With Advanced or Metastatic Malignancies Expressing CEA
-
CLINICAL_TRIALS study record update · 2012-11-09Phase I Study of Bryostatin-1 (NSC 339555) and Cisplatin in Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2012-11-09Phase I Trial of PS-341 in Advanced Cancers
-
CLINICAL_TRIALS study record update · 2012-11-09Phase I and Pharmacokinetic Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan